Gapping up
In reaction to earnings/guidance:
- HZO +12.5%, NOW +10.6% (also names new COO), XM +9.9%, LEVI +8.8%, STX +8.2%, CALX +7%, MEOH +7%, XLNX +6.7%, FLEX +6.3%, AVT +6.1%, TSCO +4.8%, LSTR +4.7%, STM +4.5%, BX +4%, WOLF +3.6%, MTH +3.5%, DB +3.2%, VLY +3%, SLM +2.7% (also to acquire Nitro College; also approves new $1.25 bln share repurchase program), ROK +2.2%, URI +2%, VLO +2%, CNX +1.8%, BLL +1.7%, TROW +1.5%, AOS +1.4%, DOW +1.3%, MUR +1.2%, LVS +1.1%, WHR +0.9%, MSCI +0.8%, ARAY +0.7%
Other news:
- GLPG +13.1% (names new CEO)
- ATRA +8.8% (enters into strategic manufacturing partnership with Fujifilm)
- TWNK +8.3% (to be added to S&P SmallCap 600)
- ATAI +7.6% (announces strategic collaboration with Dalriada Drug Discovery)
- EEFT +7.5% (to be added to S&P MidCap 400)
- SRRA +5.7% (prices offering offer 4074075 shares of common stock at $27.00 per share)
- CNC +4.4% (CNC and CI had preliminary discussions about takeover of CNC but talks did not lead to serious negotiations according to Bloomberg)
- NFLX +4.4% (Pershing Square and Bill Ackman announce that firm has acquired 3.1+ mln NFLX shares over last few days)
- CMP +4.1% (will move from S&P MidCap 400 to S&P SmallCap 600)
- NRXP +3.3% (publication of initial findings of BriLife vaccine-produced antibodies against Omicron variant)
- MRNA +2.8% (announces first participant dosed in phase 2 study of Omicron-specific booster candidate and publication of data on booster durability against omicron variant)
- JACK +2.6% (will move from S&P MidCap 400 to S&P SmallCap 600)
- BLL +1.7% (names new CEO)
- DKNG +1.7% (Mobile Sportsbook to launch in Louisiana on Friday)
- MRO +1.6% (increases dividend)
- UPST +1.5% (in sympathy with LC earnings report)
- DDOG +1.5% (receives FedRAMP moderate impact level authorization)
- GLNG +1.4% (provides update on Cool Co)
- NDAQ +1.2% (enters into $325 mln accelerated stock repurchase agreement)
Analyst comments:
- CLNE +6% (upgraded to Outperform from Underperform at Evercore ISI)
- DLO +2.7% (upgraded to Buy from Neutral at Goldman)
- ALB +1.9% (upgraded to Buy from Hold at HSBC Securities)
- GLW +1.5% (upgraded to Buy from Neutral at Goldman)